41213-31-4 Usage
General Description
2,6,7-Trichloro-quinoxaline is a chemical compound categorized under the quinoxalines, which denote a group of heterocyclic compounds. The molecular formula of this specific compound is C8H3Cl3N2. It is characterized by the presence of chlorine atoms as well as nitrogen atoms in its molecule. The general application of quinoxalines and their derivatives is in various fields such as pharmaceuticals, dyes, and polymers. Therefore, although its specific uses are not clearly stated, 2,6,7-Trichloro-quinoxaline may have potential application in these industries. Nonetheless, due to its chemical composition, safety precautions are required while handling it.
Check Digit Verification of cas no
The CAS Registry Mumber 41213-31-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,2,1 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 41213-31:
(7*4)+(6*1)+(5*2)+(4*1)+(3*3)+(2*3)+(1*1)=64
64 % 10 = 4
So 41213-31-4 is a valid CAS Registry Number.
41213-31-4Relevant articles and documents
COMPOSITION, CURED FILM, NEAR INFRARED RAY ABSORPTION FILTER, SOLID-STATE IMAGING DEVICE, INFRARED SENSOR, AND COMPOUND
-
Paragraph 0332, (2017/06/09)
It is possible to provide a composition that has absorption in a near infrared region and that can form a film having transparency in a visible region. Provided are a cured film, a near infrared ray absorption filter, a solid-state imaging device, an infr
HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 56, (2009/07/10)
The present invention relates to compounds of formula wherein Ar, Het, R1 and n are as defined herein and to pharmaceutically suitable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. Compounds of formula I are orexin receptor antagonists and are useful in the treatment of sleep apnea, narcolepsy, insomnia, parasomnia, jet lag syndrome, circadian rhythms disorder and sleep disorders associated with neurological diseases.
EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS AND METHODS FOR THE USE THEREOF
-
, (2008/06/13)
-